Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-17

FDA Approved: HYDROXYZINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original application for hydroxyzine hydrochloride from Rising Pharma Holdings, Inc., confirming a generic antihistamine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROXYZINE HYDROCHLORIDE (Hydroxyzine hydrochloride)

Snippet

ORIG AP for HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE HYDROCHLORIDE)